scholarly article | Q13442814 |
P819 | ADS bibcode | 2009PLoSO...4.8362A |
P356 | DOI | 10.1371/JOURNAL.PONE.0008362 |
P932 | PMC publication ID | 2791444 |
P698 | PubMed publication ID | 20027227 |
P5875 | ResearchGate publication ID | 40757740 |
P50 | author | Yair Reisner | Q99711648 |
Ninette Amariglio | Q106204024 | ||
Elias Shezen | Q116996357 | ||
Helena Katchman | Q116996358 | ||
Smadar Eventov-Friedman | Q116996359 | ||
Jasmine Jacob-Hirsch | Q47008807 | ||
Gidi Rechavi | Q65251591 | ||
P2093 | author name string | Uri Martinowitz | |
Anna Aronovich | |||
Dalit Tchorsh | |||
Orna Tal | |||
Sivan Cohen | |||
Chava Rosen | |||
Yael Klionsky | |||
P2860 | cites work | Nasal administration of osteopontin peptide mimetics confers neuroprotection in stroke. | Q46683889 |
Thrombin and protease-activated receptors (PARs) in atherothrombosis. | Q53497901 | ||
Human and porcine early kidney precursors as a new source for transplantation | Q57233878 | ||
The growth of infant hearts grafted to young and adult rats | Q68534088 | ||
Osteopontin at the tumor/host interface. Functional regulation by thrombin-cleavage and consequences for cell adhesion | Q71697587 | ||
Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin | Q71914473 | ||
THE AUTONOMOUS BEHAVIOUR OF NORMAL THYMUS GRAFTS | Q76544878 | ||
RESTRICTED GROWTH CAPACITY OF MULTIPLE SPLEEN GRAFTS | Q76805534 | ||
Anticoagulant and antithrombotic properties of intracellular protease-activated receptor antagonists | Q79430665 | ||
Stem cell regulation by the hematopoietic stem cell niche | Q81119053 | ||
Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells | Q81676385 | ||
The Decapentaplegic morphogen gradient: from pattern formation to growth regulation | Q28241130 | ||
Size control in animal development | Q28297142 | ||
RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement | Q28594711 | ||
Thrombin signalling and protease-activated receptors | Q29619601 | ||
Embryonic pig liver, pancreas, and lung as a source for transplantation: optimal organogenesis without teratoma depends on distinct time windows | Q33844988 | ||
Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain | Q34442820 | ||
Common critical pathways in embryogenesis and cancer | Q34535747 | ||
Filling out the Hippo pathway | Q34648282 | ||
Correction of hemophilia as a proof of concept for treatment of monogenic diseases by fetal spleen transplantation | Q35194002 | ||
Development of Proteinase-Activated Receptor 1 Antagonists as Therapeutic Agents for Thrombosis, Restenosis and Inflammatory Diseases | Q35551904 | ||
Protease-activated receptors in hemostasis, thrombosis and vascular biology | Q36230881 | ||
Osteopontin is a hematopoietic stem cell niche component that negatively regulates stem cell pool size | Q36403763 | ||
Thrombin generation and the pathogenesis of cancer | Q36467899 | ||
Stem-cell ecology and stem cells in motion | Q36528727 | ||
Osteopontin: a bridge between bone and blood. | Q36539604 | ||
The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. | Q36649442 | ||
Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype | Q36650343 | ||
Intertwining of thrombosis and inflammation in atherosclerosis | Q36667645 | ||
How flies get their size: genetics meets physiology | Q36670479 | ||
Hematopoietic stem cells: expression profiling and beyond | Q36672249 | ||
Protease activated receptors: clinical relevance to hemostasis and inflammation | Q36720123 | ||
Self-renewal and differentiation capacity of young and aged stem cells | Q37148596 | ||
Targeting a metalloprotease-PAR1 signaling system with cell-penetrating pepducins inhibits angiogenesis, ascites, and progression of ovarian cancer | Q37326414 | ||
Thrombin-cleaved osteopontin regulates hemopoietic stem and progenitor cell functions through interactions with alpha9beta1 and alpha4beta1 integrins. | Q38354428 | ||
Protease-activated receptor-4 inhibition protects from multiorgan failure in a murine model of systemic inflammation | Q44240698 | ||
Thrombin stimulates smooth muscle cell differentiation from peripheral blood mononuclear cells via protease-activated receptor-1, RhoA, and myocardin | Q45278736 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | e8362 | |
P577 | publication date | 2009-12-21 | |
P1433 | published in | PLOS One | Q564954 |
P1476 | title | Enhancement of pig embryonic implants in factor VIII KO mice: a novel role for the coagulation cascade in organ size control | |
P478 | volume | 4 |
Q41127494 | A novel role for factor VIII and thrombin/PAR1 in regulating hematopoiesis and its interplay with the bone structure | cites work | P2860 |
Search more.